Static spillovers in the first stage (pre-epidemic). by Cuicui Liu (1496260)

Subjects: “…phenomenon intensified significantly…”

Changes in total spillage during the second stage (in-epidemic). by Cuicui Liu (1496260)

Subjects: “…phenomenon intensified significantly…”

Dynamics of net spillage in the second stage (in-epidemic). by Cuicui Liu (1496260)

Subjects: “…phenomenon intensified significantly…”

Quantitative Proteomics Unveils the Synergistic Effects of Combination Drugs on Cytoskeleton Composition and Autophagy-Mediated Cell Death in Neuroblastoma by Pei-Chen Yu (1860772)

Subjects:

Lipidomic analysis of epidermis using LC-IMS-CID-MS reveals major changes in CKO// epidermis. by Kevin J. Mills (9270966)

Subjects:

Metabolism of lipids and lipid proteins CKO vs K5Cre Reactome by Kevin J. Mills (9270966)

Subjects:

Ceramide biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Conditional deletion of C/EBP in epidermis results in downregulation of transcripts and pathways associated with lipid biosynthesis in epidermis. by Kevin J. Mills (9270966)

Subjects:

Fatty acids, triacylglycerol and ketone body metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Cholesterol biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis. by Kevin J. Mills (9270966)

Subjects:

Localization and conditional deletion of C/EBP in SKH1 mouse epidermis. by Kevin J. Mills (9270966)

Subjects:

Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

Subjects:

The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

Subjects:

Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

Subjects:

Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

Subjects:

ROBINS-I assessments. by Martha R. Smith (20410184)

Subjects:

Exercise protocols and results of included studies. by Martha R. Smith (20410184)

Subjects:

Participant characteristics in studies of children with biopsy-proven NAFLD. by Martha R. Smith (20410184)

Subjects:

RoB 2 assessments. by Martha R. Smith (20410184)

Subjects: